Exploring the therapeutic potential of natural products in modulating miRNA networks in prostate cancer

Osama A Mohammed1

  • 1Department of Pharmacology, College of Medicine, University of Bisha, 61922, Bisha, Saudi Arabia. oamohamed@ub.edu.sa.

Insights

Natural compounds modulate microRNAs (miRNAs) to combat prostate cancer (PC). These agents influence tumor suppressors and oncogenes, offering a promising avenue for novel PC therapies.

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • Prostate cancer (PC) is a leading cause of cancer-related deaths in men, highlighting the need for new treatments.
  • MicroRNAs (miRNAs) are key regulators of gene expression involved in numerous cellular processes, including cancer development.
  • Deregulation of miRNA networks is implicated in prostate cancer progression.

Purpose of the Study:

  • To review the role of natural compounds in modulating miRNA expression for prostate cancer therapy.
  • To explore the molecular mechanisms by which phytochemicals impact miRNA networks in PC.

Main Methods:

  • Comprehensive literature survey of studies investigating natural compounds and their effects on miRNA expression in prostate cancer.
  • Analysis of identified phytochemicals and their mechanisms of action on miRNA biogenesis and function.

Main Results:

  • Various natural compounds (e.g., curcumin, EGCG, resveratrol) modulate both tumor-suppressor and oncogenic miRNAs in PC.
  • These compounds influence critical pathways regulating cell proliferation, apoptosis, and metastasis.
  • Natural agents alter miRNA levels via direct binding, epigenetic modifications, or interaction with miRNA biogenesis machinery.

Conclusions:

  • Natural compounds show significant potential as modulators of miRNA networks in prostate cancer.
  • Phytochemicals can be integrated into therapeutic strategies for PC, leading to innovative miRNA-targeted treatments.
  • Understanding these mechanisms provides a basis for developing effective natural product-based cancer therapies.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K
siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
16.5K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.4K